Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (42)
  • Open Access

    ARTICLE

    Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study

    Xiaoting Wei, Lili Mao, Zhihong Chi, Xinan Sheng, Chuanliang Cui, Yan Kong, Jie Dai, Xuan Wang, Siming Li, Bixia Tang, Bin Lian, Xieqiao Yan, Xue Bai, Li Zhou, Jun Guo, Lu Si

    Oncology Research, Vol.27, No.4, pp. 495-501, 2019, DOI:10.3727/096504018X15331163433914

    Abstract Melanoma is an aggressive malignancy with a poor prognosis. Current studies show that imatinib treatment is a promising approach in treating advanced melanoma patients harboring c-Kit mutations or amplifications. We retrospectively analyzed the clinical medical records of 78 patients with metastatic melanoma harboring c-Kit mutations or amplifications. These patients were treated with imatinib at a dose of 400 mg/day continuously unless intolerable toxicities or disease progression occurred. Endpoints for exploration included overall survival (OS), progression-free survival (PFS), objective response rate (ORR), and disease of control rate (DCR). The median OS and PFS of all patients were 13.1 and 4.2 months,… More >

  • Open Access

    ARTICLE

    Cylindromatosis Is Required for Survival of a Subset of Melanoma

    Ting La*†, Lei Jin*‡, Xiao Ying Liu*, Ze Hua Song*, Margaret Farrelly, Yu Chen Feng, Xu Guang Yan, Yuan Yuan Zhang*,† Rick F. Thorne*,*§ Xu Dong Zhang*†, Liu Teng*

    Oncology Research, Vol.28, No.4, pp. 385-398, 2020, DOI:10.3727/096504020X15861709922491

    Abstract The deubiquitinase cylindromatosis (CYLD) functions as a tumor suppressor inhibiting cell proliferation in many cancer types including melanoma. Here we present evidence that a proportion of melanoma cells are nonetheless addicted to CYLD for survival. The expression levels of CYLD varied widely in melanoma cell lines and melanomas in vivo, with a subset of melanoma cell lines and melanomas displaying even higher levels of CYLD than melanocyte lines and nevi, respectively. Strikingly, although short hairpin RNA (shRNA) knockdown of CYLD promoted, as anticipated, cell proliferation in some melanoma cell lines, it reduced cell viability in a fraction of melanoma cell… More >

  • Open Access

    ARTICLE

    uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells

    Elena Andreucci*1, Anna Laurenzana*, Silvia Peppicelli*, Alessio Biagioni*, Francesca Margheri*, Jessica Ruzzolini*, Francesca Bianchini*, Gabriella Fibbi*, Mario Del Rosso*†, Chiara Nediani*, Simona Serratì, Livia Fucci§, Michele Guida, Lido Calorini*†1

    Oncology Research, Vol.28, No.9, pp. 873-884, 2020, DOI:10.3727/096504021X16273798026651

    Abstract Malignant melanoma is a highly aggressive skin cancer characterized by an elevated grade of tumor cell plasticity. Such plasticity allows adaptation of melanoma cells to different hostile conditions and guarantees tumor survival and disease progression, including aggressive features such as drug resistance. Indeed, almost 50% of melanoma rapidly develop resistance to the BRAFV600E inhibitor vemurafenib, with fast tumor dissemination, a devastating consequence for patients’ outcomes. Vasculogenic mimicry (VM), the ability of cancer cells to organize themselves in perfused vascular-like channels, might sustain tumor spread by providing vemurafenibresistant cancer cells with supplementary ways to enter into circulation and disseminate. Thus, this… More >

  • Open Access

    RETRACTION

    Retraction notice to “MicroRNA-539 Inhibits the Epithelial-Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4” [Oncology Research 26(4) (2018) 529-536]

    Zhili Cao*1, Xiang Zheng†1, Lei Cao*, Naixin Liang*

    Oncology Research, Vol.28, No.7-8, pp. 831-831, 2020, DOI:10.3727/096504020X16231418632584

    Abstract This article has no abstract. More >

  • Open Access

    CASE REPORT

    A Primary Sacral Melanoma of Unknown Origin: A Case Report

    Ismail Bozkurt1,*, Baris Yasar1, Mehmet Baran Uslu2, Nazan Bozdogan3

    Oncologie, Vol.24, No.1, pp. 163-171, 2022, DOI:10.32604/oncologie.2022.019263

    Abstract Malignant melanoma caused by malignant transformation of melanocytes is associated with high mortality and is difficult to manage. Metastasis is not uncommon (up to 31% of all cases) and is closely associated with a poor prognosis. Although rare (4–5%), extracutaneous melanoma has been reported; however, primary malignant melanoma of the sacrum is extremely rare (only three case reports to date). Here, we present a 51-year-old patient who underwent surgical treatment for a lesion of the spinal canal and associated bony structures; extensive aggressive resection was required. She underwent partial sacrectomy and lumbo-iliac fixation (to maintain spinal stability). Pathology revealed malignant… More >

  • Open Access

    ARTICLE

    Image Masking and Enhancement System for Melanoma Early Stage Detection

    Fikret Yalcinkaya*, Ali Erbas

    Intelligent Automation & Soft Computing, Vol.33, No.3, pp. 1961-1977, 2022, DOI:10.32604/iasc.2022.024961

    Abstract Early stage melanoma detection (ESMD) is crucial as late detection kills. Computer aided diagnosis systems (CADS) integrated with high level algorithms are major tools capable of ESMD with high degree of accuracy, specificity, and sensitivity. CADS use the image and the information within the pixels of the image. Pixels’ characteristics and orientations determine the colour and shapes of the images as the pixels and associated environment are closely interrelated with the lesion. CADS integrated with Convolutional Neural Networks (CNN) specifically play a major role for ESMD with high degree of accuracy. The proposed system has two steps to produce high… More >

  • Open Access

    ARTICLE

    Melanoma Identification Through X-ray Modality Using Inception-v3 Based Convolutional Neural Network

    Saad Awadh Alanazi*

    CMC-Computers, Materials & Continua, Vol.72, No.1, pp. 37-55, 2022, DOI:10.32604/cmc.2022.020118

    Abstract Melanoma, also called malignant melanoma, is a form of skin cancer triggered by an abnormal proliferation of the pigment-producing cells, which give the skin its color. Melanoma is one of the skin diseases, which is exceptionally and globally dangerous, Skin lesions are considered to be a serious disease. Dermoscopy-based early recognition and detection procedure is fundamental for melanoma treatment. Early detection of melanoma using dermoscopy images improves survival rates significantly. At the same time, well-experienced dermatologists dominate the precision of diagnosis. However, precise melanoma recognition is incredibly hard due to several factors: low contrast between lesions and surrounding skin, visual… More >

  • Open Access

    REVIEW

    Biomedical overview of melanin. 2. Updating molecular modeling, synthesis mechanism, and supramolecular properties regarding melanoma therapy

    JUAN CARLOS STOCKERT1,2,*, ALFONSO BLÁZQUEZ-CASTRO3

    BIOCELL, Vol.46, No.6, pp. 1391-1415, 2022, DOI:10.32604/biocell.2022.019493

    Abstract

    Melanins represent one of the most ancient and important group of natural macromolecular pigments. They have multiple biological roles in almost all organisms across the Phyla, examples being photoprotection, anti-oxidative action, radical scavenger activity, and heavy metal removal. From the biomedical point of view, melanocytes are involved in the origin of melanoma tumors, and the main therapeutic advances for their treatment have been revised in Part 1 of this review. The chemical structure of eumelanin is a biological concern of great importance, and therefore, exploring theoretical molecular models and synthesis mechanisms will be here described, as well as molecular orbital… More >

  • Open Access

    ARTICLE

    Hybridization of CNN with LBP for Classification of Melanoma Images

    Saeed Iqbal1,*, Adnan N. Qureshi1, Ghulam Mustafa2

    CMC-Computers, Materials & Continua, Vol.71, No.3, pp. 4915-4939, 2022, DOI:10.32604/cmc.2022.023178

    Abstract Skin cancer (melanoma) is one of the most aggressive of the cancers and the prevalence has significantly increased due to increased exposure to ultraviolet radiation. Therefore, timely detection and management of the lesion is a critical consideration in order to improve lifestyle and reduce mortality. To this end, we have designed, implemented and analyzed a hybrid approach entailing convolutional neural networks (CNN) and local binary patterns (LBP). The experiments have been performed on publicly accessible datasets ISIC 2017, 2018 and 2019 (HAM10000) with data augmentation for in-distribution generalization. As a novel contribution, the CNN architecture is enhanced with an intelligible… More >

  • Open Access

    ARTICLE

    IoMT Enabled Melanoma Detection Using Improved Region Growing Lesion Boundary Extraction

    Tanzila Saba1, Rabia Javed2,3, Mohd Shafry Mohd Rahim2, Amjad Rehman1,*, Saeed Ali Bahaj4

    CMC-Computers, Materials & Continua, Vol.71, No.3, pp. 6219-6237, 2022, DOI:10.32604/cmc.2022.020865

    Abstract The Internet of Medical Things (IoMT) and cloud-based healthcare applications, services are beneficial for better decision-making in recent years. Melanoma is a deadly cancer with a higher mortality rate than other skin cancer types such as basal cell, squamous cell, and Merkel cell. However, detection and treatment at an early stage can result in a higher chance of survival. The classical methods of detection are expensive and labor-intensive. Also, they rely on a trained practitioner's level, and the availability of the needed equipment is essential for the early detection of Melanoma. The current improvement in computer-aided systems is providing very… More >

Displaying 21-30 on page 3 of 42. Per Page